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ABSTRACT 
Background Common histological classification schemes of actinic keratoses (AK) 
do not evaluate growth patterns at basal epidermal aspects of AK. Until now, the 
importance of basal epidermal growth patterns of AK has not been studied. 
Objective To investigate the extent of atypical keratinocytes throughout the 
epidermis and variation in basal growth patterns of AK.  
Methods AK lesions occurring on the head/face from patients seen in routine 
practice were assessed histologically. We determined histological grade (AK I-III), 
basal growth patterns of atypical keratinocytes (crowding, budding, papillary 
sprouting) and accompanying parameters.  
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Results Of the 246 lesions included, 28.0% were histologically classified as AK I, 
46.7% as AK II, and 25.2% as AK III. 26.4% of the basal growth patterns were 
classified as crowding (pro I), 49.6% as budding (pro II), 17.9% as papillary sprouting 
(pro III) and 6.1% without basal directed growth. No significant correlation of the 
histological AK I-III grading and underlying growth patterns was observed (P= 
0.4666). However, adnexal structure involvement (OR= 2.37; 95%CI 1.21-4.65), 
infiltration (OR= 2.53; 95%CI 1.31-4.90) and increased number of vessels (OR= 
2.56; 95%CI 1.42-4.65) were independent positive predictive markers for pro II and 
pro III basal growth patterns. 
Conclusions Basal growth patterns (pro I-III) in AK do not correlate with the 
established AK I-III histological grading system. Besides the degree of upward 
extension, varying degrees of downward extension exist. Histological classification 
should consider both, upwards and downward growth patterns when assessing AK. 
 
INTRODUCTION 
Actinic keratoses (AK) are regarded as early in-situ squamous cell carcinomas 
(SCC) and are frequently seen in dermatological practice1. Due to a change in 
leisure activities and demography in industrialized countries an increasing incidence 
of AK in people with fair skin types is observed. In chronically UV-exposed skin 
areas, AK present as erythematous macules, keratotic papules or plaques. They are 
diagnosed clinically and commonly classified based on the overall thickness of 
individual lesions2. However, recent studies have shown that the thickness of AK 
lesions neither correlates with its histological grading nor predicts its dysplastic 
severity3,4. To overcome the limitation of single lesion evaluation a new clinical 
classification, called the “actinic keratosis area and severity index” (AKASI), has 
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recently been proposed. This allows an objective assessment of field cancerization 
(AK severity) of the head/face based on parameters such as erythema, thickness 
and distribution5.  
Besides clinical grading, there are several histological classifications for grading 
AKs. Cockerell et al. introduced the term keratinocytic intraepidermal neoplasia (KIN) 
analogous to the cervical intra-epithelial neoplasia (CIN) and vulva intra-epithelial 
neoplasia (VIN)6,7. Three categories of KIN (KIN 1, KIN 2, and KIN 3) have been 
proposed, based on both clinical as well as histological features. However, the 
drawback of this classification is that the term KIN describes histopathological 
findings, which could also be used for other benign or epithelial neoplastic conditions 
such as seborrhoeic keratosis or Bowen’s disease8. 
Another established histological classification was described by Röwert-Huber8, 
which grades the extent of atypical keratinocytes throughout the epidermis. In grade 
AK I (mild), atypical keratinocytes are restricted to the basal and suprabasal layers, 
limited to the lower third of the epidermis. In grade AK II (moderate), atypical 
keratinocytes extend to the lower two thirds of the epidermis. In grade AK III (severe) 
full thickness atypia of the epidermis is found, and is equivalent to lesions called in 
situ SCC4,8. Despite this grading, every single AK lesion has the propensity to 
progress into invasive squamous cell carcinoma (iSCC) and subsequently 
metastasize9-11. The risk of progression of individual AK lesions into iSCC ranges 
from 0.025% to 16% per year.12-16 Irrespective of this overall progression risk, it 
remains speculative whether a gradual proliferation of atypical keratinocytes 
throughout the epidermis leads to invasive tumour growth. It is therefore not possible 
to accurately predict the progression risk of individual AK lesions. 
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AKs have been recognized as part of a disease continuum described as the 
“classical pathway”6. But a recent study revealed that mild AKs with dysplasia 
restricted to the lower part of the epidermis are most frequently found adjacent to or 
overlying iSCC. Besides this “classical” pathway, another “differentiated” pathway 
has been reported, suggesting that penetration may possibly be independent of the 
extent of atypical keratinocytes throughout different layers of the epidermis17,18. 
Additionally, another study claims that the severity of AK dysplasia and expression of 
p53 is independent of clinical and histological thickness3. These results challenge 
the biological significance of the AK I-III grading system3,17.  
Scurry stated that the contiguous AK adjacent to and presumably antecedent to a 
nearby iSCC often has budding of the epithelium and marked atypia of the basal 
layer cells, while exhibiting less obvious nuclear atypia in the suprabasal layers.19 
There are no substantial data which demonstrate that Röwert-Huber’s or Olsen’s 
classifications are part of a disease continuum in AK. Therefore, an additional 
classification to evaluate basal growth patterns is required. 
Thus, the aim of this retrospective analysis was to determine whether there is a 
correlation between the commonly used histological classification scheme for AK 
lesions proposed by Röwert-Huber and basal epidermal growth patterns of AK. 
Additionally, we investigated accompanying factors such as vascular density, 
inflammation and involvement of adnexal structures.  
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MATERIALS AND METHODS 
Study population 
This retrospective study was performed at the Skin Cancer Center of the Ruhr-
University Bochum (Bochum, Germany). The database was searched for patients 
who had undergone oncological surgery (surgical and shave excisions) for those 
with histologically diagnosed AK located on the head/face. The study was restricted 
to these sites to ensure regional histological pattern assessment to improve 
comparison. Samples from immunosuppressed patients and samples with collision 
tumours were excluded from this study. The study was approved by the ethics 
review board of the Ruhr-University Bochum and conducted according to the 
Declaration of Helsinki. 
 
Microscopic evaluation 
All hematoxylin and eosin (H&E) stained sections (4 µm of thickness) were analysed 
at scanning magnification and at 20-fold magnification. The samples were classified 
as AK I, II or III according to Röwert-Huber et al. by two independent investigators 
(LS and TD).   
The underlying basal growth pattern adjacent to the basement membrane zone was 
classified into three grades (protruding I-III). In pro I (crowding) basal atypical 
keratinocytes were seen to be crowding, resulting in a more basophilic appearance 
of the basal epidermis. In pro II (budding) small hemispheric buds were seen at the 
basal epidermis starting to protrude slightly into the upper papillary dermis and 
forming round nests of atypical keratinocytes. They were clearly distinguishable from 
overlying parts of the epidermis by their basophilic appearance. However, the overall 
thickness of these buds did not exceed the thickness of the epidermis lying on top. 
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Pro III (papillary sprouting) was defined by spiky or filiform papillary elongation of 
atypical keratinocytes protruding into upper dermis. The thickness of the papillary 
elongation exceeded the thickness of the overlying epidermis (Fig. 1). If different 
grades of growth were demonstrated throughout a single lesion, the highest grade 
was chosen to define the lesion (AK I-III grading as well as pro I-III grading).  
We defined upwards directed dysplasia (AK I-III), and downwards directed dysplasia 
(pro I-III) with a notional line drawn between the tips of upper dermal papillae and 
this was used to distinguish and evaluate both dysplastic entities, in a reproducible 
manner. Dysplasia criteria above (AK I-III) and below (pro I-III) this notional line have 
been evaluated (Fig. 2).  
Moreover, underlying inflammation was classified semi-quantitatively into mild, 
moderate and intense infiltrate. Further accompanying parameters (involvement of 
adnexal structures, numerically increase in vessels) were also investigated. In the 
absence of consistency amongst the two investigators cases were discussed at a 
double-headed microscope until agreement was achieved. 
 
Statistical analysis 
Data analysis was performed using the statistical package MedCalc software version 
15.2 (Ostend, Belgium). Distribution of data was assessed by the D`Agostino-
Pearson test. Provided there was normal distribution, data were expressed as mean 
and standard deviation (SD), otherwise as median and range. Data were analyzed 
using the Chi² test (univariate) and logistic regression procedure (multivariate). P-
values less than 0.05 were considered statistically significant. 
.  
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RESULTS 
In total, 246 AK lesions were included in this study (Table 1). The median age of 
patients in the study population was 79 (56-94) years. The majority of patients were 
male (92.3%) and most of the lesions were located on the scalp (30.9%). 
Overall, 69 lesions (28.0%) were histologically classified as AK I, 115 (46.7%) as AK 
II and 62 (25.2%) as AK III. With regards to basal growth pattern, 65 (26.4%) were 
classified as pro I (crowding), 122 (49.6%) as pro II (budding), 44 (17.9%) as pro III 
(papillary sprouting) and 15 (6.1%) were without signs of basal growth. 
No significant correlation (P = 0.4666) between histological classification (AK I–III) 
and the underlying basal growth pattern (pro I-III) could be found (Fig. 3). In AK I, we 
observed 8 (11.6%) AK lesions without basal growth, 18 (26.1%) showed pro I, 31 
(44.9%) pro II and 12 (17.4%) pro III features. In AK II, 5 (4.3%) AK lesions showed 
no basal growth, 32 (27.8%) pro I, 58 (50.4%) pro II and 20 (17.4%) had pro III 
features. In AK III, 2 (3.2%) AK lesions showed no basal growth, 15 (24.2%) pro I, 33 
(53.2%) pro II and 12 (19.4%) had pro III features. Clinical examples of varying 
upwards and downwards directed growth patterns are shown in Figure 4.  
Additionally, we found a significant association between basal growth pattern (pro I-
III) and involvement of adnexal structures (P = 0.0030), infiltration (>moderate) (P = 
0.0012) and numerically increased underlying vessels (P = 0.0012) (Fig. 5). In 
logistic multivariate regression analysis we observed, as independent positive 
predictive markers for basal growth in pro II or pro III, involvement of adnexal 
structures (OR = 2.37; 95%CI 1.21-4.65), infiltration (>moderate) (OR = 2.53; 95%CI 
1.31-4.90) and numerically increased underlying vessels (OR = 2.56; 95%CI 1.42-
4.65).   
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DISCUSSION 
Histological classification systems of AK should ideally assess lesion severity and its 
malignant potential to allow physicians to make appropriate treatment decisions8. 
Current classification systems are restricted to dysplasia in epidermal structures 
focussing on the extent of atypical keratinocytes throughout the epidermis. This 
mainly refers in analogy to classification schemes of AIN, VIN and CIN and regards 
AK progression in terms of a disease continuum. There are no data that substantiate 
Röwert-Huber’s classification proposing a disease continuum from AK I to AK III. 
Furthermore, there is no evidence to show that a continuous progression of atypical 
keratinocytes throughout the epidermis necessarily leads to iSCC. We now 
understand that this disease continuum is not universal and Scurry reported that KIN 
1 and KIN 2 lesions may progress directly to iSCC without progression to KIN 3 first. 
If the AKs from which AK-derived SCCs emerge are thus graded as KIN 1 or 2, the 
utility of the KIN 3 designation comes into doubt.19 In this regard, it remains 
speculative whether Röwert-Hubert’s classification contributes more than a 
morphological description of AK extent throughout the epidermis; predictive qualities 
with respect to tumour progression have not be demonstrated.  
The present study is to our knowledge the first to systematically investigate different 
basal growth patterns in AK lesions. We observed three different growth patterns 
which are described as crowding, budding and papillary sprouting of atypical 
keratinocytes and were defined as protruding atypical keratinocytes grade I-III (pro I-
III), accordingly. Our suggestion for a new classification of basal growth pattern does 
not show a correlation with the common histological classification scheme (AK I-III). 
An extended basal growth pattern (pro III) may be observed in mild actinic keratosis 
(AK I) and full thickness dysplasia (AK III) may only demonstrate mild proliferative 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
activity at the basement membrane zone (pro I). Thus, these classification schemes 
may complement each other. Furthermore, our classification system is easy to learn 
and easy to apply favouring its potential use in dermatopathology. 
Previous studies have described features such as “buds of atypical 
keratinocytes”8,19,20 which may exhibit a higher risk of progression, particularly in the 
context of Bowen´s disease (BD) and therefore downward growth in contrast to 
solely upwards directed growth may be of special interest in AK which progress to 
iSCC. Similar to AK III, BD is characterized by full thickness atypia throughout the 
epidermis; multinucleated cells containing clusters of nuclei are often present.21 A 
striking difference in comparison with AK is the sharp border between epidermis and 
dermis and frequently observed pigmentation at the preserved basal layer (so called 
“eyeliner sign”).22 Signs of basal growth like budding or protruding of cells towards 
the dermis are not characteristic in BD. This supports the assumption that growth 
pattern and growth direction may play an important role in terms of tumour 
progression, particularly as BD very rarely becomes invasive.19 
Moreover, recent studies have shown that a classification scheme focussing on the 
extent of dysplasia throughout the epidermis does not correlate with the risk of 
invasive growth. On the contrary, AK lesions classified as AK I have been shown to 
be the most common lesions associated with iSCC of the skin3,17. Therefore, it might 
be particularly important to focus on dysplasia at the basement membrane where it is 
highly likely that the process of invasion starts.  
Our study has also demonstrated several parameters which positively correlate with 
basal growth (pro I-III). In logistic multivariate regression analysis we found as an 
independent positive predictive marker for pro II or pro III basal growth, the 
involvement of adnexal structures as atypical keratinocytes migrate down the 
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adnexal epithelium. In the literature, sparing of the epithelium of acrosyringia and 
acrotrichia is often described as a typical histological sign of AK.6,8,23 Nevertheless, 
histological classification scheme by Cockerell states that in KIN II, involvement of 
upper acrotrichia and acrosyringia may be seen.6 Furthermore, both Cockerell´s and 
Röwert-Huber´s classification scheme describe involvement of adnexal structures as 
part of their grade III KIN/AK.6,8 Furthermore, it has been shown that patients with AK 
and follicular extension were more likely to progress towards invasive tumour.24 The 
results of our study support this evaluation in terms of an increasing risk of 
progression with higher grades of basal growth pattern.25 Our study showed more 
than a half (51.2%) of pro III graded AKs had adnexal involvement. This may have 
an impact on the choice of treatment as many lesion directed treatments target 
superficial disease and are not effective when there is deep follicular involvement, 
increasing the risk of recurrence.26,27  
Additionally our study revealed that an underlying moderate to severe inflammatory 
infiltrate was a further positive independent predictor for pro II or pro III basal growth 
patterns. Berhane et al. proposed a classification system of AK lesions based on 
underlying inflammation. However, it has not been established in routine practice 
due to its inconsistency. Thus it cannot be predicted that the presence of an infiltrate 
will lead to progression or regression of AK lesions28. Our study showed that atypical 
epidermal structures protruding deeply into the papillary dermis positively correlate 
with inflammatory infiltration. Involvement of immune cells is a characteristic feature 
of the tumour microenvironment in invasive carcinoma.29,30 Furthermore, our study 
showed numerically increased underlying vessels as an independent predictor for 
basal growth (> pro II).  
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We suggest that the histological classification scheme of AK should be amended by 
adding characteristics of basal lesion growth, which we have classified as pro I-III. 
Future studies are required to evaluate the relevance of basal proliferation in AK with 
regards to the risk of tumour progression. A histological review of AK adjacent to 
SCC could relate this histological grading adjustment to invasive tumour growth. 
In conclusion, we have to broaden our view on the morphologic features leading to 
progression of AK lesions to invasive carcinoma. Although we are not able to 
conclude if, or which aspects of growth patterns may have an impact on progression, 
this study details the first classification scheme to evaluate basal growth patterns. 
Thus, it would be particularly interesting to apply our classification scheme to AKs 
adjacent to (early) iSCCs. 
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Table1. Demographic and histological characteristics (N=246) 
 
Characteristic n (%) 
Sex 
 Male 
 Female 
 
227 (92.3) 
19 (7.7) 
Age, years 79 (56-94)a 
Location of lesion 
 Balding scalp 
 Forehead 
 Left side of the face (+ear) 
 Right side of the face (+ear) 
 
76 (30.9) 
49 (19.9) 
69 (28.0) 
48 (19.5) 
AK histological severity 
 AK I 
 AK II 
 AK III 
 
69 (28.0) 
115 (46.7) 
62 (25.2) 
AK basal growth grading 
 no basal growth 
 pro I 
 pro II 
 pro III 
 
15 (6.1) 
65 (26.4) 
122 (49.6) 
44 (17.9) 
Accompanying parameters  
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 Infiltrate (>moderate) 
 Involvement of adnexal structures 
 numerically increased vessels 
95 (38.6) 
86 (35.0) 
68 (27.6) 
 
AK, actinic keratosis; pro, basal protruding actinic keratosis 
aData are median (range). 
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